Clinical Trials
6 trialsNCT06206278 2024-08-14
Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma
LianBio LLC
Phase 2 Terminated
NCT02159066 2024-03-05
LOGIC-2
Pfizer
Phase 2 Completed
NCT02150967 2023-07-03
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
QED Therapeutics, a BridgeBio company
Phase 2 Terminated
NCT05019794 2022-06-27
FGFR
LianBio LLC
Phase 2 Unknown
NCT01975701 2019-12-04
A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
Novartis
Phase 2 Completed
NCT02160041 2019-06-18
CBGJ398XUS04
Novartis
Phase 2 Terminated